Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Is KeyCorp Well-Positioned to Support Its Capital Return Strategy?
Is KeyCorp Well-Positioned to Support Its Capital Return Strategy?

KeyCorp KEY maintains a disciplined capital distribution approach, aiming to return value to shareholders through dividends and share repurchases. In 2022, KeyCorp raised its quarterly dividend by

SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus

Summit Therapeutics SMMT reported fourth-quarter 2025 loss per share of 29 cents, wider than the Zacks Consensus Estimate of 22 cents. In the year-ago period, the company had incurred a loss of 8

TeraWulf Gears Up to Report Q4 Earnings: How to Play the Stock
TeraWulf Gears Up to Report Q4 Earnings: How to Play the Stock

TeraWulf WULF is slated to report fourth-quarter 2025 results on Feb. 26.The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $43.55 million, indicating an increase of 24.46% year

Baker Hughes (BKR) Up 13.1% Since Last Earnings Report: Can It Continue?
Baker Hughes (BKR) Up 13.1% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Baker Hughes (BKR). Shares have added about 13.1% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will

IonQ's Quantum Roadmap and Foundry Strategy Through 2030
IonQ's Quantum Roadmap and Foundry Strategy Through 2030

IonQ IONQ is positioning itself at the intersection of national security priorities and scalable quantum infrastructure. With a strengthened balance sheet and an expanded roadmap, management is

PAAS Delivers Record Revenues in 2025: Can the Rally Continue?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
PAAS Delivers Record Revenues in 2025: Can the Rally Continue?

Pan American Silver Corp. PAAS reported record revenues of $3.62 billion in 2025, marking an improvement of 28.4% from 2024. This includes a record $1.18 billion in revenues reported in the fourth

Tapestry Stock Surges 85% in a Year: Should You Book Profit?Photo, wide shot, wide-angle lens,  Toy manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/2788fcd3-d339-4592-8f5c-a3b9125dc61f.png
Tapestry Stock Surges 85% in a Year: Should You Book Profit?

Tapestry, Inc. TPR has experienced a remarkable increase in its stock price over the past year. The stock has rallied 85%, significantly outpacing the Zacks Retail-Apparel and Shoes industry’s 21%

Procter & Gamble vs. Colgate: Which Consumer Stock Has More Upside?
Procter & Gamble vs. Colgate: Which Consumer Stock Has More Upside?

In the global consumer staples arena, The Procter & Gamble Company PG and Colgate-Palmolive Company CL represent two distinct models of market leadership. PG operates as a diversified powerhouse

JPM Signals IB Strength, NII Growth & Tech Spending Jump in 2026
JPM Signals IB Strength, NII Growth & Tech Spending Jump in 2026

JPMorgan’s JPM latest investor presentation signals a cautiously optimistic 2026 outlook. At its Feb. 23 company update, management projected moderate earnings expansion, sustained investments in

CMC vs. CRS: Which Steel Stock Is the Better Buy Right Now?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
CMC vs. CRS: Which Steel Stock Is the Better Buy Right Now?

Commercial Metals Company CMC and Carpenter Technology Corporation CRS are two leading steel stocks with strong footprints. For investors interested in this space, let us analyze which stock is

MARA to Report Q4 Earnings: What's in the Upcoming Earnings Offering?
MARA to Report Q4 Earnings: What's in the Upcoming Earnings Offering?

MARA Holdings, Inc. MARA is set to report fourth-quarter 2025 results on Feb. 26, after the bell.

The Zacks Consensus Estimate for the bottom line is pegged at a loss of 23 cents per share compared

Home Depot Tops Q4 Earnings Estimates, Stock Dips on Sales Miss
Home Depot Tops Q4 Earnings Estimates, Stock Dips on Sales Miss

The Home Depot Inc. HD has reported fourth-quarter fiscal 2025 results, wherein the bottom line beat the Zacks Consensus Estimate, while the top line missed the same. However, sales and earnings per

Coherent vs. UiPath: Which AI Growth Stock Is the Better Buy?Photo, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
Coherent vs. UiPath: Which AI Growth Stock Is the Better Buy?

Both Coherent Corp. COHR and UiPath PATH are high-growth companies benefiting from rapid AI adoption across industries. These companies are tied to enterprise and data center spending, driven by AI

WBD Gears Up to Report Q4 Earnings: How to Play the Stock
WBD Gears Up to Report Q4 Earnings: How to Play the Stock

Warner Bros. Discovery WBD is slated to report fourth-quarter 2025 results on Feb. 26.The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $9.46 billion, indicating a decline of

Xometry (XMTR) Q4 Earnings and Revenues Top Estimates
Xometry (XMTR) Q4 Earnings and Revenues Top Estimates

Xometry (XMTR) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.06 per share a year ago. These figures

NexPoint Residential Trust Inc. (NXRT) Q4 FFO Surpass Estimates
NexPoint Residential Trust Inc. (NXRT) Q4 FFO Surpass Estimates

NexPoint Residential Trust Inc. (NXRT) came out with quarterly funds from operations (FFO) of $0.75 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to FFO of $0.78

Portillo's Inc. (PTLO) Q4 Earnings and Revenues Beat Estimates
Portillo's Inc. (PTLO) Q4 Earnings and Revenues Beat Estimates

Portillo's Inc. (PTLO) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.17 per share a year ago. These

NRG Energy (NRG) Beats Q4 Earnings and Revenue Estimates
NRG Energy (NRG) Beats Q4 Earnings and Revenue Estimates

NRG Energy (NRG) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.52 per share a year ago. These figures

Expeditors International (EXPD) Beats Q4 Earnings and Revenue Estimates
Expeditors International (EXPD) Beats Q4 Earnings and Revenue Estimates

Expeditors International (EXPD) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.68 per share a year ago

Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.98 per share a year

Apellis Pharmaceuticals (APLS) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Apellis Pharmaceuticals (APLS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2025, Apellis Pharmaceuticals, Inc. (APLS) reported revenue of $199.91 million, down 5.9% over the same period last year. EPS came in at $0.47, compared to -$0.29 in

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

Apellis Pharmaceuticals, Inc. (APLS) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of a loss of $0.4 per share. This compares to a loss of $0.29 per share

Expeditors International (EXPD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Expeditors International (EXPD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Expeditors International (EXPD) reported $2.86 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 3.3%. EPS of $1.49 for the same period compares to

American Tower's Q4 AFFO & Revenues Beat Estimates, Rise Y/Y
American Tower's Q4 AFFO & Revenues Beat Estimates, Rise Y/Y

American Tower Corporation AMT reported its fourth-quarter 2025 adjusted funds from operations (AFFO), attributable to AMT common stockholders, per share of $2.63, beating the Zacks Consensus

Pre-Market ReboundPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Pre-Market Rebound

Pre-market futures are busy climbing out of the deep hole Monday’s market dug for itself, particularly on the blue-chip Dow index. Tariff concerns and possible military conflict with Iran are issues